Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target

Mariëlle I. Gallegos Ruiz, Karijn Floor, Paul Roepman et al. · 2008

Read Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target by Mariëlle I. Gallegos Ruiz, Karijn Floor, Paul Roepman et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001722.txt.

Description

Mariëlle I. Gallegos Ruiz and co-authors combined gene copy data with gene activity data in lung cancer, in a 2008 PLOS ONE research article. Lung cancer kills about 1.2 million people a year worldwide, and the non-small cell form makes up 85 percent of cases. Better early diagnosis and treatment require knowing its molecular events.

By integrating gene dosage with expression, the team identified HSP90 as a potential drug target. Dosage is how many copies of each gene a tumor carries; expression is how active those genes are. The full text gives the tumor samples, the combined analysis, and the evidence for HSP90. Targets found by two data types at once are less likely to be noise, which is why this joining of methods matters.

Catalog record

CREATORMariëlle I. Gallegos Ruiz, Karijn Floor, Paul Roepman et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001722

Browse the full library · About the Tower of Babel